BRD2 and breast carcinoma: On the other hand, when comparing CD44 expression, a lower CD44 expression was found in the TT of breast cancer compared to NAT (0.8175-fold change, p = 0.0001, Figure 1), while there were no significant differences in colorectal cancer (1.049-fold change, Figure 2).